YIH
LBPH

Y-Intercept (HK)’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Y-Intercept (HK)’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,242
Closed -$574K – 1935
2024
Q2 		$574K Buy
+21,242
New +$419K 0.03% 752

Other funds holding LBPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Y-Intercept (HK)'s LBPH Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q3 2024, closing a stake of 21,242 shares — an estimated $574K sold.

Y-Intercept (HK) first reported a position in LBPH in Q2 2024 and held it in 1 quarter. The position peaked at $574K in Q2 2024. 125 funds tracked by Wall St. Rank hold LBPH as of Q3 2024.

  • Y-Intercept (HK) reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 21,242 Longboard Pharmaceuticals, Inc. Common Stock shares in Q3 2024, an estimated $574K.
  • Y-Intercept (HK) first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Y-Intercept (HK)'s Longboard Pharmaceuticals, Inc. Common Stock position peaked at $574K in Q2 2024.
  • 125 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.